Azenta, Inc. (AZTA)

US — Healthcare Sector
Peers: AKYA  ATRC  ATRI  ICUI  HAE  MMSI  ANGO  ATR  NVST    HOLX  COO  BLCO  BDX 

Automate Your Wheel Strategy on AZTA

With Tiblio's Option Bot, you can configure your own wheel strategy including AZTA - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

  • symbol AZTA
  • Rev/Share 13.859
  • Book/Share 37.2057
  • PB 0.827
  • Debt/Equity 0.0316
  • CurrentRatio 3.2195
  • ROIC -0.0364

 

  • MktCap 1408647523.0
  • FreeCF/Share 0.5663
  • PFCF 54.39
  • PE -21.5289
  • Debt/Assets 0.0263
  • DivYield 0
  • ROE -0.0364

 

  • Rating C
  • Score 2
  • Recommendation Sell
  • P/E Score 1
  • DCF Score 1
  • P/B Score 4
  • D/E Score 3

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
Upgrade AZTA Stephens Equal Weight Overweight $50 $60 Dec. 18, 2024

News

Azenta, Inc. (AZTA) Q2 2025 Earnings Call Transcript
AZTA
Published: May 07, 2025 by: Seeking Alpha
Sentiment: Neutral

Azenta, Inc. (NASDAQ:AZTA ) Q2 2025 Earnings Conference Call May 7, 2025 8:30 AM ET Company Participants Yvonne Perron - Vice President, Financial Planning & Analysis and Investor Relations John Marotta - President and Chief Executive Officer Lawrence Lin - Chief Financial Officer Conference Call Participants David Saxon - Needham & Company, LLC Vijay Kumar - Evercore Inc. Paul Knight - KeyBanc Capital Markets Inc. Matthew Stanton - Jefferies Group LLC Brendan Smith - TD Cowen Operator Greetings, and welcome to the Azenta Q2 2025 Financial Results. During the presentation, all participants will be in a listen-only mode.

Read More
image for news Azenta, Inc. (AZTA) Q2 2025 Earnings Call Transcript
Azenta Reports Second Quarter Results for Fiscal 2025, Ended March 31, 2025
AZTA
Published: May 07, 2025 by: PRNewsWire
Sentiment: Neutral

BURLINGTON, Mass. , May 7, 2025 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today reported financial results for the second quarter ended March 31, 2025.

Read More
image for news Azenta Reports Second Quarter Results for Fiscal 2025, Ended March 31, 2025
Is the Options Market Predicting a Spike in Azenta (AZTA) Stock?
AZTA
Published: March 06, 2025 by: Zacks Investment Research
Sentiment: Neutral

Investors need to pay close attention to Azenta (AZTA) stock based on the movements in the options market lately.

Read More
image for news Is the Options Market Predicting a Spike in Azenta (AZTA) Stock?

About Azenta, Inc. (AZTA)

  • IPO Date 1995-02-02
  • Website https://www.azenta.com
  • Industry Medical - Instruments & Supplies
  • CEO John P. Marotta
  • Employees 3000

Azenta, Inc. provides life science sample exploration and management solutions for the life sciences market in North America, Europe, China, the Asia Pacific, and internationally. The company operates through two reportable segments, Life Sciences Products and Life Sciences Services. The Life Sciences Products segment offers automated cold sample management systems for compound and biological sample storage; equipment for sample preparation and handling; consumables; and instruments that help customers in managing samples throughout their research discovery and development workflows. The Life Sciences Services segment provides comprehensive sample management programs, integrated cold chain solutions, informatics, and sample-based laboratory services to advance scientific research and support drug development. This segment's services include sample storage, genomic sequencing, gene synthesis, laboratory processing, laboratory analysis, biospecimen procurement, and other support services. It serves a range of life science customers, including pharmaceutical companies, biotechnology companies, biorepositories, and research institutes. The company was formerly known as Brooks Automation, Inc. and changed its name to Azenta, Inc. in December 2021. Azenta, Inc. was founded in 1978 and is headquartered in Chelmsford, Massachusetts.